cbdMD, Inc.
YCBD
$0.68
-$0.0249-3.53%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -7.80% | -9.22% | -18.02% | -19.35% | -21.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.80% | -9.22% | -18.02% | -19.35% | -21.55% |
| Cost of Revenue | -2.18% | -8.37% | -12.93% | -18.43% | -23.83% |
| Gross Profit | -11.04% | -9.72% | -20.90% | -19.91% | -20.17% |
| SG&A Expenses | -18.41% | -25.60% | -28.41% | -28.23% | -29.44% |
| Depreciation & Amortization | -24.72% | -28.33% | -31.80% | -36.15% | -3.69% |
| Other Operating Expenses | -88.16% | -90.25% | -79.67% | -77.78% | -13.57% |
| Total Operating Expenses | -21.49% | -27.82% | -29.60% | -31.79% | -25.67% |
| Operating Income | 69.51% | 82.65% | 67.44% | 64.23% | 37.24% |
| Income Before Tax | 92.21% | 99.27% | 86.54% | 83.87% | 10.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 92.21% | 99.27% | 86.54% | 83.87% | 10.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 92.21% | 99.27% | 86.54% | 83.87% | 10.47% |
| EBIT | 69.51% | 82.65% | 67.44% | 64.23% | 37.24% |
| EBITDA | 85.26% | 98.01% | 78.56% | 71.00% | 44.09% |
| EPS Basic | 96.53% | 96.09% | 90.67% | 89.92% | -4.85% |
| Normalized Basic EPS | 95.84% | 94.43% | 85.93% | 84.99% | 38.11% |
| EPS Diluted | 96.53% | 96.08% | 90.67% | 89.92% | -4.80% |
| Normalized Diluted EPS | 95.84% | 94.43% | 85.93% | 84.99% | 38.11% |
| Average Basic Shares Outstanding | 504.62% | 124.93% | 129.70% | 164.74% | 63.63% |
| Average Diluted Shares Outstanding | 504.62% | 124.93% | 129.70% | 164.74% | 63.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | 0.81% |